Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
October 2013 Volume 43 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2013 Volume 43 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family

  • Authors:
    • Caitlin M. MacCarthy
    • Vicente Notario
  • View Affiliations / Copyright

    Affiliations: Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
  • Pages: 1244-1252
    |
    Published online on: August 6, 2013
       https://doi.org/10.3892/ijo.2013.2052
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Expression of the ENTPD5/mt-PCPH onco­protein and overexpression of the normal ENTPD5/PCPH protein contribute to the malignant transformation of diverse mammalian cell types, and PCPH is mutated and/or deregulated in various human tumor types. Expression of PCPH or mt-PCPH caused similar phenotypes, yet the effects promoted by mt-PCPH expression were consistently and substantially greater. ATP depletion and increased stress‑resistance are phenotypes commonly associated with PCPH and mt-PCPH expression. It was suggested that the intrinsic nucleoside triphosphate diphosphohydrolase (NTPDase) activity of PCPH and mt-PCPH may be responsible for these phenotypes, but direct supporting evidence remains to be established. Results from experiments designed to test such hypothesis demonstrate that, as expected, mt-PCPH expression in human colorectal carcinoma (CRC) cells decreased their ATP levels and conferred resistance to oxaliplatin, a colorectal cancer-relevant chemotherapeutic agent. Using a combination of site-directed mutagenesis, immunoprecipitation methods, in vitro enzyme activity assays and in situ enzyme activity determinations in live cells, this report also demonstrates that the mt-PCPH oncoprotein lacks detectable NTPDase activity, indicating that direct ATP cleavage by mt-PCPH did not cause the ATP depletion observed in mt-PCPH-expressing CRC cells. These results strongly suggest that the mt-PCPH oncoprotein may regulate the cellular energy levels and subsequent chemoresistance by an NTPDase-independent mechanism. Understanding possible alternative mechanisms will be essential to devise strategies for the successful treatment of predictably therapeutically resistant tumors expressing either increased PCPH levels or, particularly, the mt-PCPH oncoprotein.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1. 

Cairns RA, Harris IS and Mak TW: Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95. 2011. View Article : Google Scholar : PubMed/NCBI

2. 

Warburg O: On respiratory impairment in cancer cells. Science. 124:269–270. 1956.PubMed/NCBI

3. 

Sattler UG, Hirschhaeuser F and Mueller-Klieser WF: Manipulation of glycolysis in malignant tumors: fantasy or therapy? Curr Med Chem. 17:96–108. 2010. View Article : Google Scholar : PubMed/NCBI

4. 

Hardt PD, Mazurek S, Toepler M, et al: Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer. 91:980–984. 2004.PubMed/NCBI

5. 

Chan EC, Koh PK, Mal M, et al: Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res. 8:352–361. 2009. View Article : Google Scholar

6. 

Walenta S, Chau TV, Schroeder T, et al: Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol. 129:321–326. 2003. View Article : Google Scholar : PubMed/NCBI

7. 

Robson SC, Sevigny J and Zimmermann H: The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2:409–430. 2006. View Article : Google Scholar : PubMed/NCBI

8. 

Enjyoji K, Kotani K, Thukral C, et al: Deletion of cd39/entpd1 results in hepatic insulin resistance. Diabetes. 57:2311–2320. 2008. View Article : Google Scholar : PubMed/NCBI

9. 

Read R, Hansen G, Kramer J, Finch R, Li L and Vogel P: Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest. Vet Pathol. 46:491–504. 2009. View Article : Google Scholar

10. 

Notario V, Castro R, Flessate DM, Doniger J and DiPaolo JA: Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens. Oncogene. 5:1425–1430. 1990.PubMed/NCBI

11. 

Velasco JA, Avila MA and Notario V: The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress. Oncogene. 18:689–701. 1999. View Article : Google Scholar : PubMed/NCBI

12. 

Fang M, Shen Z, Huang S, et al: The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell. 143:711–724. 2010. View Article : Google Scholar : PubMed/NCBI

13. 

Recio JA, Páez JG, Sanders S, Kawakami T and Notario V: Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein. Cancer Res. 62:2690–2694. 2002.PubMed/NCBI

14. 

Tirado OM, Mateo-Lozano S, Sanders S, Dettin LE and Notario V: The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation. Cancer Res. 63:6290–6298. 2003.PubMed/NCBI

15. 

Villar J, Quadri HS, Song I, Tomita Y, Tirado OM and Notario V: PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Cα-mediated Bcl-2 stabilization. Cancer Res. 69:102–110. 2009.PubMed/NCBI

16. 

Rouzaut A, Recio JA and Notario V: Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines. Radiat Res. 155:181–187. 2001. View Article : Google Scholar : PubMed/NCBI

17. 

Blánquez MJ, Arenas MI, Conde I, Tirado OM, Paniagua R and Notario V: Deregulated expression of the PCPH proto-oncogene in human breast cancers. Int J Oncol. 25:821–830. 2004.PubMed/NCBI

18. 

Villar J, Arenas MI, MacCarthy CM, Blánquez MJ, Tirado OM and Notario V: PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer Res. 67:10859–10868. 2007. View Article : Google Scholar : PubMed/NCBI

19. 

Murphy-Piedmonte DM, Crawford PA and Kirley TL: Bacterial expression, folding, purification and characterization of soluble NTPDase5 (CD39L4) ecto-nucleotidase. Biochim Biophys Acta. 1747:251–259. 2005. View Article : Google Scholar : PubMed/NCBI

20. 

Recio JA, Páez JG, Maskeri B, Loveland M, Velasco JA and Notario V: Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1. Cancer Res. 60:1720–1728. 2000.

21. 

Le Guezennec X, Vermeulen M, Brinkman AB, et al: MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol. 26:843–851. 2006.PubMed/NCBI

22. 

Smith TM and Kirley TL: Site-directed mutagenesis of a human brain ecto-apyrase: evidence that the E-type ATPases are related to the actin/heat shock 70/sugar kinase superfamily. Biochemistry. 38:321–328. 1999. View Article : Google Scholar : PubMed/NCBI

23. 

Wachstein M and Meisel E: Histochemistry of hepatic phosphatases of a physiologic pH; with special reference to the demonstration of bile canaliculi. Am J Clin Pathol. 27:13–23. 1957.PubMed/NCBI

24. 

Abramoff MD, Magelhaes PJ and Ram SJ: Image processing with Image. J Biophotonics Int. 11:36–42. 2004.

25. 

Li Y, Park JS, Deng JH and Bai Y: Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex. J Bioenerg Biomembr. 38:283–291. 2006. View Article : Google Scholar : PubMed/NCBI

26. 

Mulero JJ, Yeung G, Nelken ST and Ford JE: CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates. J Biol Chem. 274:20064–20067. 1999. View Article : Google Scholar : PubMed/NCBI

27. 

Trombetta ES and Helenius A: Glycoprotein reglucosylation and nucleotide sugar utilization in the secretory pathway: identification of a nucleoside diphosphatase in the endoplasmic reticulum. EMBO J. 18:3282–3292. 1999. View Article : Google Scholar

28. 

Mulero JJ, Yeung G, Nelken ST, Bright JM, McGowan DW and Ford JE: Biochemical characterization of CD39L4. Biochemistry. 39:12924–12928. 2000. View Article : Google Scholar : PubMed/NCBI

29. 

Yang F, Hicks-Berger CA, Smith TM and Kirley TL: Site-directed mutagenesis of human nucleoside triphosphate diphosphohydrolase 3: the importance of residues in the apyrase conserved regions. Biochemistry. 40:3943–3950. 2001. View Article : Google Scholar

30. 

Smith TM, Lewis Carl SA and Kirley TL: Mutagenesis of two conserved tryptophan residues of the E-type ATPases: inactivation and conversion of an ecto-apyrase to an ecto-NTPase. Biochemistry. 38:5849–5857. 1999. View Article : Google Scholar : PubMed/NCBI

31. 

Miura P, Thompson J, Chakkalakal JV, Holcik M and Jasmin BJ: The utrophin A 5′-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers. J Biol Chem. 280:32997–33005. 2005.

32. 

Baykov AA, Evtushenko OA and Avaeva SM: A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem. 171:266–270. 1988. View Article : Google Scholar : PubMed/NCBI

33. 

Zhang JT and Ling V: Involvement of cytoplasmic factors regulating the membrane orientation of P-glycoprotein sequences. Biochemistry. 34:9159–9165. 1995. View Article : Google Scholar : PubMed/NCBI

34. 

Massé K, Eason R, Bhamra S, Dale N and Jones EA: Comparative genomic and expression analysis of the conserved NTPDase gene family in Xenopus. Genomics. 87:366–381. 2006.PubMed/NCBI

35. 

Recio JA, Zambrano N, de la Peña L, et al: cDNA isolation, expression, and chromosomal localization of the mouse pcph proto-oncogene. Mol Carcinog. 26:130–136. 1999. View Article : Google Scholar : PubMed/NCBI

36. 

Ivanenkov VV, Murphy-Piedmonte DM and Kirley TL: Bacterial expression, characterization, and disulfide bond determination of soluble human NTPDase6 (CD39L2) nucleotidase: implications for structure and function. Biochemistry. 42:11726–11735. 2003. View Article : Google Scholar

37. 

Zebisch M and Strater N: Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling. Proc Natl Acad Sci USA. 105:6882–6887. 2008. View Article : Google Scholar : PubMed/NCBI

38. 

Crawford PA, Gaddie KJ, Smith TM and Kirley TL: Characterization of an alternative splice variant of human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): a possible modulator of nucleotidase activity and purinergic signaling. Arch Biochem Biophys. 457:7–15. 2007. View Article : Google Scholar

39. 

Riewe D, Grosman L, Fernie AR, Wucke C and Geigenberger P: The potato-specific apyrase is apoplastically localized and has influence on gene expression, growth, and development. Plant Physiol. 147:1092–1109. 2008. View Article : Google Scholar : PubMed/NCBI

40. 

Regadera J, Blánquez MJ, González-Peramato P, et al: PCPH expression is an early event in the development of testicular germ cell tumors. Int J Oncol. 28:595–604. 2006.PubMed/NCBI

41. 

Mikula M, Rubel T, Karczmarski J, Goryca K, Dadlez M and Ostrowski J: Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics. 11:215–224. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
MacCarthy CM and Notario V: The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family. Int J Oncol 43: 1244-1252, 2013.
APA
MacCarthy, C.M., & Notario, V. (2013). The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family. International Journal of Oncology, 43, 1244-1252. https://doi.org/10.3892/ijo.2013.2052
MLA
MacCarthy, C. M., Notario, V."The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family". International Journal of Oncology 43.4 (2013): 1244-1252.
Chicago
MacCarthy, C. M., Notario, V."The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family". International Journal of Oncology 43, no. 4 (2013): 1244-1252. https://doi.org/10.3892/ijo.2013.2052
Copy and paste a formatted citation
x
Spandidos Publications style
MacCarthy CM and Notario V: The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family. Int J Oncol 43: 1244-1252, 2013.
APA
MacCarthy, C.M., & Notario, V. (2013). The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family. International Journal of Oncology, 43, 1244-1252. https://doi.org/10.3892/ijo.2013.2052
MLA
MacCarthy, C. M., Notario, V."The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family". International Journal of Oncology 43.4 (2013): 1244-1252.
Chicago
MacCarthy, C. M., Notario, V."The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family". International Journal of Oncology 43, no. 4 (2013): 1244-1252. https://doi.org/10.3892/ijo.2013.2052
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team